globaltaxnews.ey.comSign up for tax alert emailsForwardPrintDownload |
30 April 2018 How robotics is reshaping the biopharma value chain A tireless digital robotic workforce that puts in work 24/7 can bring companies’ return on investment (ROI) up to 600% to 800% in three years, according to the London School of Economics. EY explores the top reasons why pharma companies should embrace robotic process automation (RPA). Document ID: 2018-5580 |